ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $2.82M invested in Eledon Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$42.6K
2
+$2K

Top Sellers

1
-$201K
2
-$187K
3
-$38K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$14.6K
5
VF
Virtu Financial
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.85M
2
$481K
3
$264K
4
$174K
5
$22K
6
$19K
7
$7K
8
$2K
9
$2K
10
–
11
–
12
–
13
–
14
–